Evidence map›Paper›PMID 25135669›Full record

ArticleMolecular & cellular proteomics : MCP2014

The development and application of a quantitative peptide microarray based approach to protein interaction domain specificity space.

Brett W Engelmann, Yohan Kim, Miaoyan Wang, Bjoern Peters, Ronald S Rock, Piers D Nash

Open access · hybridAbstract read
In one paragraph

Article in Molecular & cellular proteomics : MCP, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
1.3field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 17 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Brett W EngelmannFrom the ‡The Department of Biochemistry and Molecular Biology, The University of Chicago, Chicago, Illinois 60637; bengelmann@uchicago.edu.
Yohan Kim¶The La Jolla Institute for Allergy and Immunology, La Jolla, California 92037;
Miaoyan Wang‖The Department of Statistics, The University of Chicago, Chicago, Illinois 60637;
Bjoern Peters¶The La Jolla Institute for Allergy and Immunology, La Jolla, California 92037;
Ronald S RockFrom the ‡The Department of Biochemistry and Molecular Biology, The University of Chicago, Chicago, Illinois 60637;
Piers D Nash**The Ben May Department for Cancer Research, The University of Chicago, Chicago, Illinois 60637.
University of Chicago · USLa Jolla Institute for Immunology · US

Funding

Molecular And Cellular Biology Training ProgramT32GM007183 · NIGMS · UNIVERSITY OF CHICAGO · PI GLICK, BENJAMIN S, RICE, PHOEBE A · 1985 to 2021
$23.9M
Re-Engineering Translational Research at the University of ChicagoUL1TR000430 · NCATS · UNIVERSITY OF CHICAGO · PI SOLWAY, JULIAN · 2012 to 2016
$20.2M
Allostery in myosins studied at the molecular levelR01GM078450 · NIGMS · UNIVERSITY OF CHICAGO · PI ROCK, RONALD S · 2006 to 2015
$2.8M
NCATS NIH HHS UL1 TR000430NIGMS NIH HHS GM 078450NIGMS NIH HHS R01 GM078450NIGMS NIH HHS T32 GM007183NIGMS NIH HHS TG-GM07183
6 · The paper itself

Abstract

Protein interaction domain (PID) linear peptide motif interactions direct diverse cellular processes in a specific and coordinated fashion. PID specificity, or the interaction selectivity derived from affinity preferences between possible PID-peptide pairs is the basis of this ability. Here, we develop an integrated experimental and computational cellulose peptide conjugate microarray (CPCMA) based approach for the high throughput analysis of PID specificity that provides unprecedented quantitative resolution and reproducibility. As a test system, we quantify the specificity preferences of four Src Homology 2 domains and 124 physiological phosphopeptides to produce a novel quantitative interactome. The quantitative data set covers a broad affinity range, is highly precise, and agrees well with orthogonal biophysical validation, in vivo interactions, and peptide library trained algorithm predictions. In contrast to preceding approaches, the CPCMAs proved capable of confidently assigning interactions into affinity categories, resolving the subtle affinity contributions of residue correlations, and yielded predictive peptide motif affinity matrices. Unique CPCMA enabled modes of systems level analysis reveal a physiological interactome with expected node degree value decreasing as a function of affinity, resulting in minimal high affinity binding overlap between domains; uncover that Src Homology 2 domains bind ligands with a similar average affinity yet strikingly different levels of promiscuity and binding dynamic range; and parse with unprecedented quantitative resolution contextual factors directing specificity. The CPCMA platform promises broad application within the fields of PID specificity, synthetic biology, specificity focused drug design, and network biology.

Indexed as

AlgorithmsCelluloseEscherichia coliGene ExpressionGlycoconjugatesHigh-Throughput Screening AssaysPeptide LibraryPhosphopeptidesProtein Array AnalysisProtein BindingProtein Interaction MappingRecombinant Fusion ProteinsReproducibility of ResultsSensitivity and Specificitysrc Homology DomainsCelluloseGlycoconjugatesPeptide LibraryPhosphopeptidesRecombinant Fusion Proteins

Identifiers

PMID25135669
PMCPMC4256512
OpenAlexW2096571448

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.